Rajesh Pahwa, MD

Quick facts

Marketed products

• Mirapex · Other

Phase 3 pipeline

• Requip PR · Neurology
  Requip PR is a dopamine agonist that stimulates dopamine receptors in the brain to increase dopamine activity.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Rajesh Pahwa, MD portfolio CI brief
• Rajesh Pahwa, MD pipeline updates RSS